OPTICROM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Opticrom, and what generic alternatives are available?
Opticrom is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in OPTICROM is cromolyn sodium. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the cromolyn sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Opticrom
A generic version of OPTICROM was approved as cromolyn sodium by SANDOZ on June 16th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OPTICROM?
- What are the global sales for OPTICROM?
- What is Average Wholesale Price for OPTICROM?
Summary for OPTICROM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 98 |
Patent Applications: | 4,783 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OPTICROM at DailyMed |
![OPTICROM drug patent expirations Drug patent expirations by year for OPTICROM](/p/graph/s/t/OPTICROM-patent-expirations.png)
US Patents and Regulatory Information for OPTICROM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | OPTICROM | cromolyn sodium | SOLUTION/DROPS;OPHTHALMIC | 018155-001 | Oct 3, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OPTICROM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Allergan | OPTICROM | cromolyn sodium | SOLUTION/DROPS;OPHTHALMIC | 018155-001 | Oct 3, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | OPTICROM | cromolyn sodium | SOLUTION/DROPS;OPHTHALMIC | 018155-001 | Oct 3, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | OPTICROM | cromolyn sodium | SOLUTION/DROPS;OPHTHALMIC | 018155-001 | Oct 3, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | OPTICROM | cromolyn sodium | SOLUTION/DROPS;OPHTHALMIC | 018155-001 | Oct 3, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | OPTICROM | cromolyn sodium | SOLUTION/DROPS;OPHTHALMIC | 018155-001 | Oct 3, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OPTICROM
See the table below for patents covering OPTICROM around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Netherlands | 177386 | ⤷ Sign Up | |
Japan | S5341662 | ⤷ Sign Up | |
United Kingdom | 1144905 | ⤷ Sign Up | |
Norway | 124875 | ⤷ Sign Up | |
Philippines | 12747 | BIS-CHROMONYL COMPOUNDS AND DERIVATIVES THEREOF,PHARMACEUTICAL COMPOSITIONS THEREOF AND METHOD OF USING THE SAME | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |